NOT KNOWN DETAILS ABOUT SEMAGLUTUDE WEEKS 13-16 BUNDLE

Thyroid C-mobile Tumors: In rodent research, semaglutide is shown to trigger thyroid C-cell tumors. It's unfamiliar whether this hazard relates to individuals, but semaglutide is contraindicated in individuals with a personal or family background of medullary thyroid carcinoma (MTC) or sufferers with A number of Endocrine Neoplasia syndrome type tw